Search research articles
Contact Us
Filters
Showing results (31-40 of 58) with videos related to
Page
of 6
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 4, 2010
Phase II study of everolimus (RAD001) in previously treated small cell lung cancer
Ahmad Tarhini, Athanasios Kotsakis, William Gooding, et al.
Audiology & Neuro-Otology
|
May 28, 2025
Response to Oral Steroids for Sudden Sensorineural Hearing Loss: Considerations of Age, Time to Treatment, and Degree of Hearing Loss
Erin Harvey, Grace Callan, Neil Osafo, et al.
The Pediatric Infectious Disease Journal
|
April 20, 2016
A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone
Christopher R Cannavino, Agnes Nemeth, Bartosz Korczowski, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2018
Plasma and Intrapulmonary Concentrations of Cefepime and Zidebactam following Intravenous Administration of WCK 5222 to Healthy Adult Subjects
Keith A Rodvold, Mark H Gotfried, Rakesh Chugh, et al.
Melanoma Research
|
May 17, 2007
Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents
Stergios J Moschos, Christine Odoux, Stephanie R Land, et al.
International Journal of Antimicrobial Agents
|
February 5, 2019
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials
G Ralph Corey, Mark H Wilcox, Jesus Gonzalez, et al.
The Journal of Antimicrobial Chemotherapy
|
December 26, 2015
Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials
Maria Taboada, David Melnick, Joseph P Iaconis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 11, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection
G Ralph Corey, Mark Wilcox, George H Talbot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 12, 2010
Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia
Thomas M File, Donald E Low, Paul B Eckburg, et al.
Antimicrobial Agents and Chemotherapy
|
July 24, 2019
Single-Center Investigation of the Pharmacokinetics of WCK 4282 (Cefepime-Tazobactam Combination) in Renal Impairment
Richard A Preston, Grigor Mamikonyan, Mushtaque Mastim, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 58) with videos related to
Sort By:
Page
of 6
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 4, 2010
Phase II study of everolimus (RAD001) in previously treated small cell lung cancer
Ahmad Tarhini, Athanasios Kotsakis, William Gooding, et al.
Audiology & Neuro-Otology
|
May 28, 2025
Response to Oral Steroids for Sudden Sensorineural Hearing Loss: Considerations of Age, Time to Treatment, and Degree of Hearing Loss
Erin Harvey, Grace Callan, Neil Osafo, et al.
The Pediatric Infectious Disease Journal
|
April 20, 2016
A Randomized, Prospective Study of Pediatric Patients With Community-acquired Pneumonia Treated With Ceftaroline Versus Ceftriaxone
Christopher R Cannavino, Agnes Nemeth, Bartosz Korczowski, et al.
Antimicrobial Agents and Chemotherapy
|
May 23, 2018
Plasma and Intrapulmonary Concentrations of Cefepime and Zidebactam following Intravenous Administration of WCK 5222 to Healthy Adult Subjects
Keith A Rodvold, Mark H Gotfried, Rakesh Chugh, et al.
Melanoma Research
|
May 17, 2007
Endostatin plus interferon-alpha2b therapy for metastatic melanoma: a novel combination of antiangiogenic and immunomodulatory agents
Stergios J Moschos, Christine Odoux, Stephanie R Land, et al.
International Journal of Antimicrobial Agents
|
February 5, 2019
Ceftaroline fosamil therapy in patients with acute bacterial skin and skin-structure infections with systemic inflammatory signs: A retrospective dose comparison across three pivotal trials
G Ralph Corey, Mark H Wilcox, Jesus Gonzalez, et al.
The Journal of Antimicrobial Chemotherapy
|
December 26, 2015
Ceftaroline fosamil versus ceftriaxone for the treatment of community-acquired pneumonia: individual patient data meta-analysis of randomized controlled trials
Maria Taboada, David Melnick, Joseph P Iaconis, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 11, 2010
Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection
G Ralph Corey, Mark Wilcox, George H Talbot, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
November 12, 2010
Integrated analysis of FOCUS 1 and FOCUS 2: randomized, doubled-blinded, multicenter phase 3 trials of the efficacy and safety of ceftaroline fosamil versus ceftriaxone in patients with community-acquired pneumonia
Thomas M File, Donald E Low, Paul B Eckburg, et al.
Antimicrobial Agents and Chemotherapy
|
July 24, 2019
Single-Center Investigation of the Pharmacokinetics of WCK 4282 (Cefepime-Tazobactam Combination) in Renal Impairment
Richard A Preston, Grigor Mamikonyan, Mushtaque Mastim, et al.
Page
of 6